Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Propionibacterium acnes (now commonly renamed Cutibacterium acnes) is a Gram-positive, anaerobic bacterium that forms a major component of the human skin microbiome but can also function as an opportunistic pathogen [2][7]. Its cell wall and membrane are characteristic of Gram-positive bacteria, consisting of a thick peptidoglycan layer, teichoic acids, and distinct lipid components including phosphatidylinositol and triacylglycerol [7]. The cell wall contains virulence factors such as surface proteins (e.g., DsA1), adhesins, and enzymes (lipases, proteases), and mediates essential functions such as adherence to host tissues, immune system activation (including stimulation of proinflammatory cytokines through TLR2 and other pathways [4]), and robust biofilm formation on host surfaces and implanted devices [1][2][4]. The biofilm matrix incorporates extracellular DNA and proteins, protecting bacteria from antibiotics and host defenses. The cell wall/membrane is targeted by several antibiotics and experimental antimicrobial peptides, making it a valid but complex therapeutic target. However, "Propionibacterium acnes cell wall/membrane" refers to a broad bacterial structural component rather than a single defined protein, receptor, or molecular target, which limits its utility as a precise pharmacological target.
Disruption or inhibition of cell wall synthesis (cell wall-targeting antibiotics); Disruption of membrane/cell wall integrity (antimicrobial peptides/enzymes); Inhibition of biofilm formation; Immune recognition and activation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Propionibacterium acnes cell wall.